Roles for miRNAs in endocrine resistance in breast cancer

被引：89

作者：

Muluhngwi, Penn ^{[1
]}

Klinge, Carolyn M. ^{[1
]}

机构：

[1] Univ Louisville, Sch Med, Ctr Genet & Mol Med, Dept Biochem & Mol Genet, Louisville, KY 40292 USA

来源：

ENDOCRINE-RELATED CANCER | 2015年 / 22卷 / 05期

基金：

美国国家卫生研究院;

关键词：

antiestrogen; aromatase inhibitor; breast cancer; endocrine-resistance; estrogen receptor; miRNA; tamoxifen; ESTROGEN-RECEPTOR-ALPHA; NF-KAPPA-B; SIGNAL-TRANSDUCTION INHIBITORS; CONFERS TAMOXIFEN RESISTANCE; EXOSOME-MEDIATED TRANSFER; AROMATASE INHIBITORS; MESSENGER-RNAS; POSTMENOPAUSAL WOMEN; DOWN-REGULATION; UP-REGULATION;

D O I：

10.1530/ERC-15-0355

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Therapies targeting estrogen receptor alpha (ER alpha), including selective ER modulators such as tamoxifen, selective ER downregulators such as fulvestrant (ICI 182 780), and aromatase inhibitors such as letrozole, are successfully used in treating breast cancer patients whose initial tumor expresses ER alpha. Unfortunately, the effectiveness of endocrine therapies is limited by acquired resistance. The role of microRNAs (miRNAs) in the progression of endocrine-resistant breast cancer is of keen interest in developing biomarkers and therapies to counter metastatic disease. This review focuses on miRNAs implicated as disruptors of antiestrogen therapies, their bona fide gene targets and associated pathways promoting endocrine resistance.

引用

收藏

页码：R279 / R300

页数：22

相关论文

共 192 条

[1]

S-palmitoylation modulates human estrogen receptor-α functions [J].

Acconcia, F ;

Ascenzi, P ;

Fabozzi, G ;

Visca, P ;

Marino, M .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 316 (03) :878-883

[2]

Argonaute-2 Expression Is Regulated by Epidermal Growth Factor Receptor and Mitogen-Activated Protein Kinase Signaling and Correlates with a Transformed Phenotype in Breast Cancer Cells [J].

Adams, Brian D. ;

Claffey, Kevin P. ;

White, Bruce A. .

ENDOCRINOLOGY, 2009, 150 (01) :14-23

[3]

Influence of Berry Polyphenols on Receptor Signaling and Cell-Death Pathways: Implications for Breast Cancer Prevention [J].

Aiyer, Harini S. ;

Warri, Anni M. ;

Woode, Denzel R. ;

Hilakivi-Clarke, Leena ;

Clarke, Robert .

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2012, 60 (23) :5693-5708

[4]

Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer [J].

Anbalagan, Muralidharan ;

Rowan, Brian G. .

MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2015, 418 :264-272

[5]

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J].

Anzick, SL ;

Kononen, J ;

Walker, RL ;

Azorsa, DO ;

Tanner, MM ;

Guan, XY ;

Sauter, G ;

Kallioniemi, OP ;

Trent, JM ;

Meltzer, PS .

SCIENCE, 1997, 277 (5328) :965-968

[6]

Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: Molecular mechanism and clinical implications for endocrine therapy resistance [J].

Arpino, Grazia ;

Wiechmann, Lisa ;

Osborne, C. Kent ;

Schiff, Rachel .

ENDOCRINE REVIEWS, 2008, 29 (02) :217-233

[7]

Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc [J].

Barletta, F ;

Wong, CW ;

McNally, C ;

Komm, BS ;

Katzenellenbogen, B ;

Cheskis, BJ .

MOLECULAR ENDOCRINOLOGY, 2004, 18 (05) :1096-1108

[8]

MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].

Bartel, David P. .

CELL, 2007, 131 (04) :11-29

[9]

Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes [J].

Baskerville, S ;

Bartel, DP .

RNA, 2005, 11 (03) :241-247

[10]

BAUM M, 1983, LANCET, V2, P450

← 1 2 3 4 5 6 7 8 9 10 →